Ascentage Pharma Group International (HKG:6855)
Hong Kong · Delayed Price · Currency is HKD 31.32
+0.76 (2.49%)
Oct 21, 2026, 1:45 PM HKT
HKG:6855 Market Cap
HKG:6855 has a market cap or net worth of 11.52 billion as of October 20, 2026. It is the 8,061st most valuable company in the world and the 413th biggest in Hong Kong. Its market cap has decreased by 54.15% in one year.
Market Cap
11.52B
Enterprise Value
11.76B
Revenue
741.90M
Global Rank
Country Rank
#413 Hong Kong
PE Ratio
n/a
ChartMarket Cap Chart
Since October 28, 2019, HKG:6855's market cap has increased from 7.59B to 11.52B, an increase of 51.79%. That is a compound annual growth rate of 6.16%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2026 | 11.52B | -40.11% |
| Dec 31, 2025 | 19.23B | 36.66% |
| Dec 31, 2024 | 14.07B | 81.16% |
| Dec 29, 2023 | 7.77B | 17.12% |
| Dec 30, 2022 | 6.63B | -8.70% |
| Dec 31, 2021 | 7.26B | -14.53% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 28, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Duality Biotherapeutics | 15.39B |
| Metis TechBio | 14.10B |
| Everest Medicines | 11.38B |
| GenFleet Therapeutics (Shanghai) | 10.32B |
| Suzhou Ribo Life Science | 8.63B |
| HBM Holdings | 8.56B |
| Nanjing Leads Biolabs | 8.06B |
| Shaanxi Micot Pharmaceutical Technology | 7.96B |